Your shopping cart is currently empty.
How expensive are the drugs and products that your lab or pharmaceutical facility uses on a daily basis?
According to one peer-reviewed paper, the average cost of developing a new drug or vaccine can range anywhere from $200 million to $500 million. Such an extremely high price tag for developing life-saving vaccines and drugs means that every single drop counts.
However, this concern isn’t unique to pharmaceutical companies. IVF labs working with micro specimens cannot afford to lose even the tiniest amount.
For this reason, more laboratories and pharmaceutical companies are switching over from conventional needles to Low Dead Space (LDS) Needles. Read on to learn more about the newest LDS needle from TSK and why it’s becoming the needle of choice when material waste is a consideration.
A standard needle used for lab and pharmaceutical purposes contains a “dead space” at the tip that prevents a portion of the product from being used when the plunger is pushed down. This dead space averages out to around 99µl of wasted product.
Also known as a low-dead volume needle, a low dead space needle features a design that limits the amount of product left behind after each injection or use. This translates to greater cost savings and helps prevent the waste of limited-supply products.
The TSK Low Dead Space Needle reduces the amount of product waste to near-zero. The patented LDS hub design results in significant product savings and potential cost savings when working with expensive or limited supply drugs.
One example of the invaluable nature of the TSK Low Dead Space Needle can be seen in its use in developing and administering life-saving vaccines like the COVID-19 vaccine.
Yahoo! News ran a story in November of 2020 that reported that 4 to 8 million additional people could be vaccinated if clinics were to use the TSK Low Dead Space Needle technology to administer the vaccine. In their report, Yahoo! News claimed:
“Using a conservative estimate this could lead to a savings of 20 microliters per dose, and in an optimistic scenario even 40 microliters per dose can be saved. This represents somewhere between 4 and 8 percent based on the assumption that a vaccine dose is 0.5 millilitres.”
TSK offers a wide range of needle sizes that are not commonly available in the U.S. For example, the smallest needle that one of the largest hypodermic needle manufacturers carries is 32G. TSK offers a much smaller .2mm LDS needle option (essentially 34G).
The hub of the LDS needle from TSK allows for an extremely tight Luer Lock connection due to the built-in exterior threading. This helps prevent the hub from leaking and “popping-off” if exposed to high pressures.
The TSKiD™ large needle barrels have an enlarged inner diameter that requires less extrusion force and allows for a more controlled, and therefore smoother, injection.
TSK LDS needle hubs are manufactured from an extremely hard polymer that also helps prevent flexing, leaking, and needle pop-off when exposed to high pressures.
TSK Low Dead Space Needles can help conserve every last drop of an expensive or limited-supply product. At Air-Tite, we carry various sizes of LDS needles that will add value to your lab or pharmaceutical operation. Click below to view our products.
Most product options are available through a wide range of national distribution partners. Please contact us for cross-reference information.
